BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 27450916)

  • 1. Promoter hypermethylation of miR-34a contributes to the risk, progression, metastasis and poor survival of laryngeal squamous cell carcinoma.
    Shen Z; Zhou C; Li J; Ye D; Li Q; Wang J; Cui X; Chen X; Bao T; Duan S
    Gene; 2016 Nov; 593(2):272-6. PubMed ID: 27450916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LZTS2 promoter hypermethylation: a potential biomarker for the diagnosis and prognosis of laryngeal squamous cell carcinoma.
    Shen Z; Lin L; Cao B; Zhou C; Hao W; Ye D
    World J Surg Oncol; 2018 Mar; 16(1):42. PubMed ID: 29499699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinical Signification of Claudin-11 Promoter Hypermethylation for Laryngeal Squamous Cell Carcinoma.
    Shen Z; Cao B; Lin L; Zhou C; Ye D; Qiu S; Li Q; Cui X
    Med Sci Monit; 2017 Jul; 23():3635-3640. PubMed ID: 28743857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SSTR2 promoter hypermethylation is associated with the risk and progression of laryngeal squamous cell carcinoma in males.
    Shen Z; Chen X; Li Q; Zhou C; Li J; Ye H; Duan S
    Diagn Pathol; 2016 Jan; 11():10. PubMed ID: 26796520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ESRRG promoter hypermethylation as a diagnostic and prognostic biomarker in laryngeal squamous cell carcinoma.
    Shen Z; Hu Y; Zhou C; Yuan J; Xu J; Hao W; Deng H; Ye D
    J Clin Lab Anal; 2019 Jul; 33(6):e22899. PubMed ID: 31002184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated methylation of CMTM3 promoter in the male laryngeal squamous cell carcinoma patients.
    Shen Z; Chen X; Li Q; Zhou C; Xu Y; Yu R; Ye H; Li J; Duan S
    Clin Biochem; 2016 Nov; 49(16-17):1278-1282. PubMed ID: 27521994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of miR-29c-3p is associated with a poor prognosis in patients with laryngeal squamous cell carcinoma.
    Fang R; Huang Y; Xie J; Zhang J; Ji X
    Diagn Pathol; 2019 Oct; 14(1):109. PubMed ID: 31615536
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Shen Z; Zhou C; Li J; Ye D; Deng H; Cao B; Hao W; Lin L; Zhang Y
    Biomed Res Int; 2017; 2017():9058749. PubMed ID: 28299336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
    Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of mRNA expression level and hypermethylation of CHFR promoter in the laryngeal squamous cell carcinoma tissue].
    He L; Ji W; Yang J; Zhao X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Aug; 24(15):673-7. PubMed ID: 20942233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter Methylation-Regulated miR-145-5p Inhibits Laryngeal Squamous Cell Carcinoma Progression by Targeting FSCN1.
    Gao W; Zhang C; Li W; Li H; Sang J; Zhao Q; Bo Y; Luo H; Zheng X; Lu Y; Shi Y; Yang D; Zhang R; Li Z; Cui J; Zhang Y; Niu M; Li J; Wu Z; Guo H; Xiang C; Wang J; Hou J; Zhang L; Thorne RF; Cui Y; Wu Y; Wen S; Wang B
    Mol Ther; 2019 Feb; 27(2):365-379. PubMed ID: 30341010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression Levels and Clinical Significance of miR-21-5p, miR-let-7a, and miR-34c-5p in Laryngeal Squamous Cell Carcinoma.
    Re M; Magliulo G; Gioacchini FM; Bajraktari A; Bertini A; Çeka A; Rubini C; Ferrante L; Procopio AD; Olivieri F
    Biomed Res Int; 2017; 2017():3921258. PubMed ID: 29082244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of miR-34a by aberrant CpG methylation in Kazakh patients with esophageal carcinoma.
    Cui X; Zhao Z; Liu D; Guo T; Li S; Hu J; Liu C; Yang L; Cao Y; Jiang J; Liang W; Liu W; Li S; Wang L; Wang L; Gu W; Wu C; Chen Y; Li F
    J Exp Clin Cancer Res; 2014 Feb; 33(1):20. PubMed ID: 24528540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RUNX3 inhibits laryngeal squamous cell carcinoma malignancy under the regulation of miR-148a-3p/DNMT1 axis.
    Jili S; Eryong L; Lijuan L; Chao Z
    Cell Biochem Funct; 2016 Dec; 34(8):597-605. PubMed ID: 27859417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long intergenic noncoding RNA HOTAIR is overexpressed and regulates PTEN methylation in laryngeal squamous cell carcinoma.
    Li D; Feng J; Wu T; Wang Y; Sun Y; Ren J; Liu M
    Am J Pathol; 2013 Jan; 182(1):64-70. PubMed ID: 23141928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of microRNA-34a in esophageal squamous cell carcinoma.
    Lin X; Xu XY; Chen QS; Huang C
    Genet Mol Res; 2015 Dec; 14(4):17684-91. PubMed ID: 26782413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reciprocal regulation of miR-1205 and E2F1 modulates progression of laryngeal squamous cell carcinoma.
    Li P; Lin XJ; Yang Y; Yang AK; Di JM; Jiang QW; Huang JR; Yuan ML; Xing ZH; Wei MN; Li Y; Yuan XH; Shi Z; Liu H; Ye J
    Cell Death Dis; 2019 Dec; 10(12):916. PubMed ID: 31801947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1.
    Ye J; Li L; Feng P; Wan J; Li J
    Oncol Rep; 2016 Jul; 36(1):390-8. PubMed ID: 27220728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Methylation status of uPA promoter in laryngeal squamous cell carcinoma].
    Wang D; Wang T; Ren Z
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 May; 20(9):409-11. PubMed ID: 16836076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-196b is a prognostic factor of human laryngeal squamous cell carcinoma and promotes tumor progression by targeting SOCS2.
    Zhao X; Zhang W; Ji W
    Biochem Biophys Res Commun; 2018 Jun; 501(2):584-592. PubMed ID: 29753737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.